Health ❯ Healthcare

Pharmaceutical Industry

Drug Development Drug Pricing Generic Drugs Market Trends Drug Manufacturing Vaccine Development Drug Manufacturers Drug Approval Process Drug Approval Generic Medicines

Merck Reports Q1 Loss From Cidara Charge as Sales Beat and 2026 Outlook Rises

A one-time deal cost turned a strong sales quarter into a loss.

FDA Launches First Real-Time Clinical Trial Pilot With AstraZeneca and Amgen

Cost Plus Drugs and Humana’s CenterWell Strike Employer Pharmacy Partnership

Revolution Medicines’ Pancreatic Cancer Drug Lands ASCO Plenary After Phase 3 Survival Gain

Mexico Launches IMPI–COFEPRIS Portal for Real-Time Health Patent Data

HSBC Cuts Eli Lilly to Reduce, Lowers Target to $850 on GLP-1 Reset

Plaintiff Firms Urge Inovio Investors to Seek Lead Role in Securities Suit by April 7

Sanofi Replaces Paul Hudson, Names Belén Garijo as Next CEO

GSK Lifts 2025 Profit, Sets Cooler 2026 Outlook Under New CEO

Tanya Mittal Denies '150 Bodyguards' Claim, Opens Pharma Factory to Media

Insilico Medicine Surges on Hong Kong Debut After HK$2.3 Billion IPO

Pfizer Sets 2026 Targets Below Wall Street as COVID Sales Fade, Patent Pressure Builds

Mexico Pays Nearly 15 Billion Pesos to Drugmakers, Bars Repeat Contracts for Defaulters

Federation Council Pledges Support for FMBA, Hailing It as the ‘Special Forces’ of Russian Healthcare

Study Finds FDA Pivotal Trials Rarely Reflect U.S. Diversity as Black and Hispanic Enrollment Falls

Nivin Pauly’s Pharma Sets JioHotstar Premiere for December 19 With Multilingual Release

Russia Proposes Delaying Four Vaccine Additions to Immunization Calendar

Abbott Recalls FreeStyle Libre 3 Sensors in 17 Countries After Reports of False Low Readings

Eli Lilly Briefly Hits $1 Trillion, First Drugmaker to Reach the Milestone

MHRA Unveils Overhaul to Speed Rare-Disease Drug Approvals